VERTEX PHARMACEUTICALS INC - DEF 14A

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

April 8, 2021

Period of Report

May 19, 2021

Accession Number

0001308179-21-000196

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →